Sign in
Active, not recruitingNo phase

Harmony TPV Post-Approval Study

Key facts

Who runs it
Medtronic Cardiovascular
Where
Ann Arbor, Aurora, Birmingham, Boston, Charleston, Charlotte, Charlottesville, Cincinnati, Cleveland, Dallas, Durham, Los Angeles, New York, Oak Lawn, Omaha, Pittsburgh, St Louis, and Tampa, United StatesSee the 19 sitesAlso in 1 other country, 1 site
Trial code
Status
Active, not recruiting
People taking part
174 people enrolled
Started
25 Oct 2021
Expected to end
Mar 2035
Type of study
Interventional
Treatments tested
  • Harmony TPV System
Record updated
1 October 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Patient eligible to receive the Harmony TPV, meeting the indications for use criteria per current geography-specific device labeling at time of study enrollment
  • Patient (or patient's legally authorized representative) is willing to consent to participate in the study

Who cannot take part

  • Planned concomitant branch pulmonary artery stenting at time of implant
  • Subject is pregnant at time of implant procedure
  • Patients with previously treated with an RV-PA conduit or previously implanted bioprosthesis
  • A major or progressive non-cardiac disease (e.g. liver failure, renal failure, cancer) that results in a life expectancy of less than one year
  • Planned implantation of the Harmony TPV in the left heart
  • Pre-existing prosthetic heart valve or prosthetic ring in any position
  • Obstruction of the central veins
  • Echocardiographic evidence of intracardiac mass, thrombus, or vegetation

Where in United States

Also in 1 other country, 1 site

  • University of Michigan Health SystemAnn Arbor, United States
  • Children's Hospital ColoradoAurora, United States
  • University of Alabama At Birmingham HospitalBirmingham, United States
  • Boston Children's HospitalBoston, United States
  • Medical University of South CarolinaCharleston, United States
  • Atrium Health/Levine Children's HospitalCharlotte, United States
  • University of VirginiaCharlottesville, United States
  • Cincinnati Children's Hospital Medical CenterCincinnati, United States
  • Cleveland ClinicCleveland, United States
  • Medical City Children's HospitalDallas, United States
  • Duke University Medical CenterDurham, United States
  • Cedars-Sinai Medical CenterLos Angeles, United States
  • Children's Hospital New York-PresbyterianNew York, United States
  • The Mount Sinai HospitalNew York, United States
  • Advocate Christ Medical CenterOak Lawn, United States
  • Children'S Hospital & Medical CenterOmaha, United States
  • UPMC Children's Hospital of PittsburghPittsburgh, United States
  • Saint Louis Children's HospitalSt Louis, United States
  • St. Joseph Children's HospitalTampa, United States

About the trial

What the trial wants to find out

The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (TPV) achieved by real-world implanters.

The group in the trial

  • Harmony TPV SystemOther group

    Intervention Device: Harmony Transcatheter Pulmonary Valves and Delivery System

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Harmony TPV Post-Approval Study (Harmony PAS2)
Publications
Record updated
1 October 2026